In This Article:
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES
Vancouver, British Columbia, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) announces that it has entered into a M&A credit facility to fund transaction expenses and closing costs associated with acquisitions such as rocket Doctor. The credit facility is up to $1.5 million at an annual interest rate of 12% and for a term of 18 months. The credit facility is unsecured and is repayable in cash only and no securities of the company are issuable in connection with the facility. Dr. Essam Hamza, CEO of Treatment.com AI, comments: “We are pleased to have a non-dilutive credit facility to assist the company in financing our growth through accretive, revenue building acquisitions”.
About Treatment.com AI Inc.
Treatment.com AI is a company utilizing AI and best clinical practices to positively disrupt the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, Treatment has built a comprehensive, personalized healthcare AI engine, the Global Library of Medicine (GLM). Providing highly qualified clinical information and support to all healthcare professionals, as well as providing recommended tests (physical and lab), x-rays, and billing codes. The GLM helps healthcare professionals (doctor, nurse or pharmacist) reduce their administrative burden; create more time for needed face to face patient appointments and has the propensity for greater consistency in quality of patient support. Treatment’s GLM platform also brings the possibility of health equity and inclusion for disenfranchised communities. To learn more about Treatment’s products and services: www.treatment.com or email: info@treatment.com
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO
For media inquiries, contact: media@treatment.com
Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955
Cautionary Statement
This news release contains forward-looking statements relating to the future operations of Treatment and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, are forward- looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment's expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators.